|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0025344,
umls-concept:C0079083,
umls-concept:C0205179,
umls-concept:C0278996,
umls-concept:C0282461,
umls-concept:C0332173,
umls-concept:C0439234,
umls-concept:C0443196,
umls-concept:C0521115,
umls-concept:C0547043,
umls-concept:C1274040,
umls-concept:C1517927,
umls-concept:C1519810,
umls-concept:C1522449,
umls-concept:C1522577,
umls-concept:C1561960,
umls-concept:C1948053,
umls-concept:C2347804
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-6-24
|
|
pubmed:abstractText |
Radiotherapy is the conventional treatment for locally advanced inoperable head and neck squamous cell carcinoma. However, the poor therapeutic results justify the development of radiochemotherapy combinations. In an attempt to improve local control and survival in patients with stage III and IV unresectable head and neck squamous cell carcinoma and based on the results of our previous dose escalation study, we undertook a prospective multicentric randomized trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-8916
|
|
pubmed:author |
pubmed-author:AllisSimonaS,
pubmed-author:BeltramoGiancarloG,
pubmed-author:FossatiPieroP,
pubmed-author:GabrieleAnna MariaAM,
pubmed-author:GabrielePietroP,
pubmed-author:La PortaMaria RosaMR,
pubmed-author:MelanoAntonellaA,
pubmed-author:MoroGregorioG,
pubmed-author:OrecchiaRobertoR,
pubmed-author:RagonaRiccardoR,
pubmed-author:RampinoMonicaM,
pubmed-author:RicardiUmbertoU,
pubmed-author:Ruo ReddaMaria GraziaMG,
pubmed-author:TessaMariellaM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
96
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
246-53
|
|
pubmed:meshHeading |
pubmed-meshheading:20572581-Adult,
pubmed-meshheading:20572581-Aged,
pubmed-meshheading:20572581-Antineoplastic Agents,
pubmed-meshheading:20572581-Carboplatin,
pubmed-meshheading:20572581-Combined Modality Therapy,
pubmed-meshheading:20572581-Female,
pubmed-meshheading:20572581-Follow-Up Studies,
pubmed-meshheading:20572581-Head and Neck Neoplasms,
pubmed-meshheading:20572581-Humans,
pubmed-meshheading:20572581-Male,
pubmed-meshheading:20572581-Middle Aged,
pubmed-meshheading:20572581-Prospective Studies,
pubmed-meshheading:20572581-Radiotherapy,
pubmed-meshheading:20572581-Time Factors
|
|
pubmed:articleTitle |
Radiotherapy alone or with concomitant daily low-dose carboplatin in locally advanced, unresectable head and neck cancer: definitive results of a phase III study with a follow-up period of up to ten years.
|
|
pubmed:affiliation |
Radiation Oncology Unit of University of Turin, Ospedale S Luigi Gonzaga, Orbassano, Italy. mariagrazia.ruoredda@unito.it
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Clinical Trial, Phase III
|
